Violeta Georgieva

#health #innovation @AstraZeneca

[Violeta Georgieva @VioletaGeor]

Excellent news for #AstraZeneca and people around the EU & the world 👏👏👏

[Stella Kyriakides @SKyriakidesEU]

Today we reached a settlement agreement w/ @AstraZeneca.
This includes a binding commitment to deliver all #COVID19 vaccines under our contract.

We are pleased to have found a mutually satisfactory solution that benefits 🇪🇺citizens & 🌍 citizens via our global COVAX commitment.

[Violeta Georgieva @VioletaGeor]

Join us next week for a 🇪🇺 #Health🧬policy talk

[EuropaBio @EuropaBio]

📅 June 3, 2021 | 2 pm CEST

🤹‍♂️Join our #Healthcare #Biotechnology Team for a dive into #EU #policies that will impact and shape your future strategies.

📍REGISTER NOW: https://t.co/QxCJ8jP0UW

@SMEEurope @ESBA_Europe @SMEunited @connectsmes @EU_EISMEA @VioletaGeor @KinsellaDE

[Violeta Georgieva @VioletaGeor]

@EU_Health is called upon to rethink the application of 🇪🇺 outdated #GMO rules to transformative #genetherapies @EuropaBio @EFPIA @alliancerm

[EuropaBio @EuropaBio]

👉 @EuropaBio, @alliancerm & @EFPIA jointly call for #AdvancedTherapies to be #exempt from EU #GMO Legislation, to #accelerate ⏳ access to life-changing #medicines for European #patients. 🧪

Read sp: ➡️ https://t.co/voaj82zz2j
Read the paper:➡️ https://t.co/veMpYFgFZz

[Violeta Georgieva @VioletaGeor]

Meet the most innovative #cellandgenetherapy developers and committed regulators and policy makers at @EuropaBio series of webinars to discuss the future of # #healthcare
Kick-off on 11 May!

[EuropaBio @EuropaBio]

We have just launched EuropaBio Advanced Therapies Series. 🥳💥

📍The first event under the title ‘Taking health up a gear: value of advanced therapies’ will take place on May 11, from 12h00 to 13h00 (CEST). Register here: https://t.co/jJuNQ7wbQX

Are you coming?🤔

[Violeta Georgieva @VioletaGeor]

The uptake of #innovation in #cancer care and treatment must happen at pace and scale to overcome the setbacks caused by #COVID19 and progress further
@cancereu @EuropaBio #WorldHealthDay2021

[International Alliance for Personalised Medicine @united4cancer]

❗ We are launching a joint letter showing the cancer community's willingness to support governments in their effort to help cancer patients globally! Thanks to the 292 cancer stakeholders that have supported the initiative #COVID19andCancer

➡️https://t.co/13BX66yHQD

[Violeta Georgieva @VioletaGeor]

Delighted to share our work with @WS_Brussels @cancereu @EUneurology @spietikainen & @EuropaBio on campaigning #PatientEmpowerment 👏👏👏
Shall we systematically and meaningfully involve patients in the entire innovative #medicine lifecycle!

[EuropaBio @EuropaBio]

📢 WE ARE #HIRING!

@EuropaBio is looking for a new #intern to join the #Healthcare #Biotechnology Team!

For more information about the role, and how to apply, check out our website: https://t.co/gQZI3sVDkS

[Violeta Georgieva @VioletaGeor]

Now @EuropaBio webinar on #economic footprint of 🇪🇺#Biotechnology industry
Why wonder about the rapid delivery of #COVID19 #vaccinesavelives & #therapeutics if the biopharmaceutical & health biotech industry have been invested massively in R&D over a long sting of years

[EuropaBio @EuropaBio]

Join #EuropaBio TOMORROW to find out more about the #economic #footprint of biotechnology in #Europe and be part of the discussion on its role in future economic #recovery and delivering #healthy #people and #planet.

Register here! ➡️ https://t.co/k2zLDFedDS

[Violeta Georgieva @VioletaGeor]

So excited about celebrating 25 years of immense contributions of #Biotechnology to our society when today #biotech-derived #VaccinesSaveLives amid #COVID19!
#sciencewillwin #InnovationForEveryone
Tune in with @EuropaBio ➡️https://t.co/Pp0Sjs7B6l

[EuropaBio @EuropaBio]

@EuropaBio kicks off 2021 #celebrations to mark its #foundation a quarter of a #century ago, and plans to #showcase the most significant #advances in #European #Biotechnology over the last 25 years!

💥2️⃣5️⃣💥

Follow the celebrations on➡️https://t.co/6jSp3NURit!

[Violeta Georgieva @VioletaGeor]

#RareDiseaseDay2021
So much more knowledge, investment & collaborations are needed. #Biotechnology #innovations should be further supported to fill the gaps bn rare & regular

[Violeta Georgieva @VioletaGeor]

#Manufacturing complex #biological products is not simply about capacity and volumes, but capability and know-how. Read @NathalieMoll on why it is a waste of time to blame #COVID19Vaccine woes on #IP

[EFPIA @EFPIA]

Only medical innovation can stem the devastating cost of #COVID19. Fostering a research eco-system that can deliver innovation rather than undermining it through challenges to IP is the best way to protect people https://t.co/SG1tHWy19u #WeWontRest

[Violeta Georgieva @VioletaGeor]

Learn about the economic footprint of one of the 🇪🇺 most innovative & research-intensive industries with @EuropaBio & @WifOR_Institute on March 4

[EuropaBio @EuropaBio]

Join @EuropaBio on March 4 to find out more about the the #economic #footprint of biotechnology in #Europe and be part of the discussion on its role in future economic #recovery and delivering #healthy #people and #planet.

Register here! ➡️ https://t.co/k2zLDFedDS

[EuropaBio @EuropaBio]

Join #EuropaBio on March 4 to find out more about the the #economic #footprint of biotechnology in #Europe and be part of the discussion on its role in future economic #recovery and delivering #healthy #people and #planet.

Register now! ➡️ https://t.co/k2zLDFedDS

[Violeta Georgieva @VioletaGeor]

Well-functioning 🇪🇺 #CrossBorderHealthcare legislation should ensure #patients have #access2medicine such as #cellandgenetherapy & #RareDisease medicines when these are not available in their home country

[EuropaBio @EuropaBio]

EuropaBio sees the #Directive on #CrossBorderHealthcare as a key tool to ensure #patient access to the best available #care, particularly in the case of #AdvancedTherapies & #Medicines for #RareDiseases.

Read here our full response to the consultation:⬇️

https://t.co/JPesIpYNWj

[Violeta Georgieva @VioletaGeor]

New @EuropaBio study on #biotech #industry footprint in 🇪🇺
#healthcare #biotech is accelerating for the benefit of #patients
Hooray!

[EuropaBio @EuropaBio]

#Europe’s Biotech #Boost: €78bn and 900,000 #Jobs! 🧬

Discover the ‘Economic Footprint of the #Biotechnology Industry in Europe’! ➡️ https://t.co/k4vdVVAkxv 🧬

Join us on March 4th to find out more! ➡️ https://t.co/k2zLDFedDS 🧬

[Violeta Georgieva @VioletaGeor]

Europeans carry 25% of the global population’s #cancer burden. Striking! Big hopes for success of #EUCancerPlan on #worldcancerday2021
Deeply convinced #health #biotech medical solutions will continue changing the prospects of cancer #patients
@EU_Health @EP_BeatCancer

[EuropaBio @EuropaBio]

#ATMPs are a new generation of innovative #medicines based on #genes, #cells or #tissues which bring the potential to cure #cancer and to improve #patients’ life expectancy and #quality of #life.

Read more: ➡️ https://t.co/bJqh4pZJao

#WorldCancerDay #WorldCancerDay2021

[Violeta Georgieva @VioletaGeor]

Encouraged by @EU_Health's recognition of new technologies & highly personalised advanced therapies as a "powerful tool" of the future of cancer treatment in #EUCancerPlan today @EuropaBio

[EuropaBio @EuropaBio]

Advanced #cancer treatments require an environment that is supportive of #healthcare innovation, and the #EUCancerPlan is a critical instrument for ensuring that. @EuropaBio fully supports the @EU_Commission's "all hands on deck" approach against cancer. @GrimmBj

[Violeta Georgieva @VioletaGeor]

#EUCancerPlan Day

[EuropaBio @EuropaBio]

#Gene and #CellTherapies hold the potential to #revolutionise the way #cancer will be treated in the #future. Looking forward to the launch of the #EUCancerPlan today. @EU_Health

[Violeta Georgieva @VioletaGeor]

As we are eagerly waiting for #EUCancerPlan this week #DYK cell therapy has advanced most in #oncology - 665 out of all 1,078 clinical trials with advanced therapies globally (as of H1 2020) were in #oncology @EU_Health @EP_BeatCancer @cancereu